JannMW, GarreltsJC, EreshefskyL, SakladSR. Alternative drug therapies for mania: a literature review.Drug Intell Clin Pharm1984; 18: 577–89.
2.
HakolaHPA, LaulumaaVA. Carbamazepine in treatment of violent schizophrenics (letter).Lancet1982; 1: 1358.
3.
LuchinsDJ. Carbamazepine for the violent psychiatric patient (letter).Lancet1983; 1: 766.
4.
HerreraJM, SramekJJ, CostaJF. Efficacy of adjunctive carbamazepine in the treatment of chronic schizophrenia.Drug Intell Clin Pharm1987; 21: 355–8.
5.
KimDY, HollisterLE. Thioxthixene in the intensive treatment of drug-refractory chronic schizophrenics: doses and plasma concentrations. Scientific exhibit, 34th American Psychiatric Association Institute on Hospital and Community Psychiatry, Louisville, KY, October, 1982.
6.
BertilssonL, HojerB, TybringG. Autoinduction of carbamazepine metabolism in children examined by a stable isotope technique.Clin Pharmacol Ther1980; 27: 83–8.
7.
EichelbaumM, BertilssonL, RaneA. Kinetics and metabolism of carbamazepine during combined antiepileptic drug therapy.Clin Pharmacol Ther1979; 26: 366–71.
8.
SchneiderM. Carbamazepine. The influence of other antiepileptic drugs on its serum level.Eur J Clin Pharmacol1975; 8: 183–95.
9.
EichelbaumM, EkbomK, BertilssonL, RingbergerV, RaneA. Plasma kinetics of carbamazepine in man; 10,11- epoxide during treatment of epilepsy.Eur J Clin Pharmacol1975; 8: 337–41.
10.
JannMW, EreshefskyL, SakladSR. Effects of carbamazepine on plasma haloperidol levels.J Clin Psychopharmacol1985; 5: 106–9.